Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1671 1682
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18210213 | METHODS OF DETECTING SIGNATURES OF DISEASE OR CONDITIONS IN BODILY FLUIDS | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17482765 | Method of Determining Secondary Structure of a Nucleic Acid | Final Rejection | President and Fellows of Harvard College |
| 18515185 | Compositions and Methods for Detecting Staphylococcus Aureus | Final Rejection | Gen-Probe Incorporated |
| 17675589 | BIOMARKER COMPOSITION, DIAGNOSTIC KIT, AND METHOD FOR PROVIDING INFORMATION | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18037361 | SENSITIVE QUANTITATIVE DETECTION OF SARS-CoV-2 USING DIGITAL WARM-START CRISPR ASSAY | Non-Final OA | UNIVERSITY OF CONNECTICUT |
| 18245048 | METHODS OF PATHOGEN IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TESTING | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 17590986 | METHODS AND COMPOSITIONS FOR DETECTING ESOPHAGEAL NEOPLASIAS AND/OR METAPLASIAS IN THE ESOPHAGUS | Non-Final OA | Case Western Reserve University |
| 17904568 | METHODS FOR DETECTING NTRK GENE FUSION USING RNA IN SITU HYBRIDIZATION | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 18467927 | METHODS OF SPECIFICALLY LABELING NUCLEIC ACIDS USING CRISPR/CAS | Non-Final OA | Drexel University |
| 18035239 | USE OF TORQUE TENO VIRUS (TTV) AS A MARKER TO DETERMINE THE PROLIFERATIVE CAPACITY OF T LYMPHOCYTES | Non-Final OA | UNIVERSITE CLAUDE BERNARD LYON 1 |
| 18007114 | POLYNUCLEOTIDE, POLYNUCLEOTIDE SET, METHOD FOR DETECTING PORPHYROMONAS GINGIVALIS, METHOD FOR ASSESSING PERIODONTAL DISEASE SUSCEPTIBILITY, PORPHYROMONAS GINGIVALIS DETECTION KIT, AND PERIODONTAL DISEASE SUSCEPTIBILITY ASSESSMENT KIT | Non-Final OA | MITSUI CHEMICALS, INC. |
| 17999169 | Method of Detecting Analytes in a Sample | Non-Final OA | Siemens Healthcare Diagnostics Inc. |
| 17783997 | ENHANCED DISEASE RESISTANCE OF MAIZE TO NORTHERN CORN LEAF BLIGHT BY A QTL ON CHROMOSOME 4 | Final Rejection | KWS SAAT SE & Co. KGaA |
| 18042434 | LAMP DETECTION OF SARS-COV-2 IN SALIVA FOR THE RAPID DIAGNOSIS OF COVID-19 | Non-Final OA | CITY OF HOPE |
| 17958516 | METHODS OF DIAGNOSING CANCER AND PREDICTING RESPONSIVENESS TO THERAPY | Non-Final OA | Yeda Research and Development Co. Ltd. |
| 18306548 | COMPOSITIONS AND METHODS FOR DIAGNOSING LUNG CANCERS USING GENE EXPRESSION PROFILES | Final Rejection | The Wistar Institute of Anatomy and Biology |
| 18163936 | TARGET RNA DETECTION METHOD BASED ON DCAS9/GRNA COMPLEX | Final Rejection | BIONANO HEALTH GUARD RESEARCH CENTER |
| 18111996 | DETECTION OF BACTERIAL INFECTIONS | Final Rejection | The University of Liverpool |
| 18267743 | METHOD FOR IN VITRO DIAGNOSIS OF MUCOSITIS IN CANCER PATIENTS UNDERGOING ANTITUMOR THERAPY | Non-Final OA | ISTITUTI FISIOTERAPICI OSPITALIERI |
| 18148039 | METHODS FOR DETECTING RNA TRANSLATION | Final Rejection | Eclipse Bioinnovations, Inc. |
| 18193073 | Methods for Salmonella Serovar Analysis and Differentiation | Non-Final OA | PathogenDx, Inc. |
| 18106394 | METHODS OF DETECTING TRICHOMONAS TENAX | Non-Final OA | Adtalem Global Education Inc. |
| 18101052 | Differential Methylation Level of CpG Loci That Are Determinative of a Biochemical Reoccurrence of Prostate Cancer | Final Rejection | Board of Directors of the Leland Stanford Junior University |
| 18015912 | METHODS FOR DETECTING LIVER CANCER | Non-Final OA | New Day Diagnostics LLC |
| 18093092 | Composition and method for predicting preterm birth using microbiome analysis of vaginal fluid of pregnant women | Final Rejection | EWHA University Industry Collaboration Foundation |
| 17830731 | METHOD FOR IDENTIFYING M1 GENERATION PLANT MUTANTS RESULTING FROM PHYSICAL AND CHEMICAL MUTAGENESIS AND FOR ACQUIRING MUTANT, IDENTIFICATION OF GENOTYPING PRIMER FOR ORYZA SATIVA MUTATION, MUTANT GENE, AND USE THEREOF | Non-Final OA | HUNAN HYBRID RICE RESEARCH CENTER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy